Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

mTOR

Items 11-20 of 27

Page
per page
  1. OSI-027
    B1637 OSI-027
    Summary: MTORC1/ mTORC2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥32.5 mg/mL
  2. AKT/mTOR Set I
    A9904 AKT/mTOR Set I
    Summary: For inhibiting AKT/mTOR
  3. Rapalink-1
    A8764 Rapalink-1
     5 Citation
    Target: mTOR
    Summary: third-generation mTOR inhibitor
      ≥178.4 mg/mL
  4. GSK2126458
    A8556 GSK2126458
     1 Citation
    Target: PI3K|mTOR
    Summary: PI3K/mTOR inhibitor
      ≥25.3 mg/mL
  5. INK 128 (MLN0128)
    A8551 INK 128 (MLN0128)
     4 Citation
    Target: mTOR
    Summary: MTOR(TORC-1/-2) inhibitor,potent and selective
      insoluble in H2O; ≥15.45 mg/mL
  6. AZD2014
    A8373 AZD2014
    Summary: Novel mTOR inhibitor
      ≥23.15 mg/mL
  7. PP242
    A8318 PP242
    Target: mTOR
    Summary: MTOR inhibitor, selective and ATP-competitive
  8. Temsirolimus
    A8314 Temsirolimus
    Summary: MTOR inhibitor
      ≥51.5 mg/mL
  9. AZD8055
    A8214 AZD8055
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥23.3 mg/mL
  10. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL

Items 11-20 of 27

Page
per page